Today's Date: March 29, 2024
Amerex Group Unveils Red Carter Swimwear's Revitalized Collection   •   Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™   •   Equalpride Partners with TransLash Media for Trans Day of Visibility, Amplifying Voices of Black Trans Femmes in the Arts   •   Empire State Realty Trust Receives WELL Health-Safety Leadership Award; Becomes Among the First Commercial Office and Multifamil   •   Anaergia Announces Delay in the Filing of Its Audited Financial Statements and Related Disclosures   •   Carnegie Learning Named 2024 SIIA CODiE Award Finalist for Best Educational Game and Best AI Implementation in Ed Tech   •   Coachella Concerned That People Have Sex, Says AHF   •   Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink   •   Sypher Secures Strategic Partnership with FAIA to Fuel Growth   •   Jamieson Wellness Publishes Inaugural Sustainability Impact Report   •   Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment to sustainability.   •   Make-A-Wish and celebrity wish granters announce goal to recruit 1 million people to become "WishMakers"   •   National University Receives 2024 Military Friendly® Gold Designation   •   VIRGIN HOTELS CHAMPIONS INCLUSIVE TRAVEL FOR NEURODIVERSE TRAVELERS   •   Visit Visalia Recognizes Autism Awareness Month in April   •   Anaergia Announces Escrow Closing of Second Tranche of the Strategic Investment   •   Fosun Management on 2023 Annual Results: Focusing on Core Industries with Established Advantages   •   Suffolk Kicks off 2024 “Build With Us @ Suffolk” Program in Boston for Trade Partners, Opening Doors for Minority-,   •   YMCA of the USA Partners With Old Spice To Increase High School Graduation Among Boys And Young Men Of Color Through Mentorship   •   Parkland Corporation Announces the Results of the 2024 Annual General Meeting of Shareholders
Bookmark and Share

Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

Appointment of Seasoned Biopharma Veteran Strengthens Growing Life Sciences Investment Firm

PR Newswire

WALTHAM, Mass., July 16, 2020 /PRNewswire/ -- Agent Capital, a majority woman-owned international life sciences investment firm supporting disruptive healthcare companies, announced the appointment of industry veteran Jacopo Leonardi as Partner. Jacopo is a proven global biopharmaceutical executive with a 25-year track record of creating sustainable growth for new ventures and underperforming franchises. The addition of Jacopo enhances Agent Capital's well-established reputation for value creation, strategic acumen, and access to premier life sciences industry talent and deals.

Jacopo's deep expertise in global commercial operations and launch excellence across multiple therapeutic areas including orphan and rare diseases, immunology, and neurology aligns with Agent Capital's investment focus on subsectors that generate the highest potential returns. In addition to his experience managing a range of functions including R&D, Medical Affairs, Manufacturing, and Quality, Jacopo brings his strong reputation as a leader and mentor known for building inspired and inclusive teams, recognizing talent, and fostering career growth, for which he was celebrated by the Healthcare Businesswomen's Association (HBA) as their 2016 Honorable Mentor of the Year.

"We are excited to have Jacopo join our team as we enter our next phase of growth and investment," said Dr. Geeta Vemuri, Managing Partner and Founder of Agent Capital. "Throughout his career Jacopo has embodied our investment philosophy – diverse management teams lead to superior investment returns and a greater ability for portfolio companies to develop the next generation of healthcare innovators and innovations. I look forward to working again with Jac to support our current and future partners on their path to success."

Founded in 2016, Agent Capital's investment strategy and diverse team have earned them access to a vast pipeline of high-value potential deals and a syndicate network of investment partners that enables them to drive portfolio growth and exit. Agent Capital's first fund (Fund I), initially focused on novel, differentiated therapeutics and treatments that address unmet patient needs, has invested in 14 healthcare companies – four of which have successfully gone public. Prior to Agent Capital the team invested for Baxter and Baxalta as corporate venture capitalists from 2012 to 2016 and had five significant trade sales in their prior portfolio. Agent Capital is poised for growth due to their track record of accelerating value creation and ability to provide industry-leading strategic thinking, R&D and commercial stewardship experience, access to top talent, and coaching and mentorship for management teams.

"I am honored to have the opportunity to work with Geeta and the Agent Capital team to continue to pursue my career-long passion of cultivating diverse teams and shepherding promising healthcare solutions from the spark of innovation to commercially successful products that make an impact on patients' lives," said Jacopo Leonardi, Partner with Agent Capital. "As an executive and entrepreneur, I am thrilled to be able to apply my experience developing and maximizing the potential of organizations and individuals to the next generation of healthcare innovation."

Prior to Agent Capital, Jacopo served on boards and in executive leadership across multiple companies in concierge health and specialty pharmacy. As an Operating Partner at The Vistria Group, Jacopo was part of a team that acquired and helped accelerate the growth of AIS Healthcare, and he currently serves on the company's board of directors. Earlier in his career, Jacopo was Executive Vice President and President of Immunology for Baxalta and has spent 20 years in key development and global leadership roles in general management, marketing, sales, and R&D at Eli Lilly, Johnson & Johnson, Baxter, and Baxalta.

ABOUT AGENT CAPITAL

Agent Capital is an international life sciences investment firm that supports disruptive healthcare companies focusing on novel, differentiated therapeutics and treatments that address unmet patient needs. Agent Capital aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations, leverages their industry expertise and successful track record to source premier deals, accelerate value, and drive successful exits. Their first fund invested in 14 portfolio companies, of which four have gone public. Agent Capital has offices in Boston, Massachusetts.

 

Cision View original content:http://www.prnewswire.com/news-releases/agent-capital-expands-management-team-appoints-jacopo-leonardi-as-partner-301094849.html

SOURCE Agent Capital



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News